Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Myelofibrosis research |
Description | Are you living with Have you been diagnosed with Myelofibrosis? Learn more about an investigational medication targeting |
Keywords | N/A |
WebSite | myelofibrosisresearch.com |
Host IP | 173.201.188.130 |
Location | United States |
Site | Rank |
US$554,055
Last updated: 2023-05-07 05:45:20
myelofibrosisresearch.com has Semrush global rank of 19,103,375. myelofibrosisresearch.com has an estimated worth of US$ 554,055, based on its estimated Ads revenue. myelofibrosisresearch.com receives approximately 63,930 unique visitors each day. Its web server is located in United States, with IP address 173.201.188.130. According to SiteAdvisor, myelofibrosisresearch.com is safe to visit. |
Purchase/Sale Value | US$554,055 |
Daily Ads Revenue | US$512 |
Monthly Ads Revenue | US$15,344 |
Yearly Ads Revenue | US$184,117 |
Daily Unique Visitors | 4,262 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
myelofibrosisresearch.com. 10799 IN | A | IP: 173.201.188.130 | |
myelofibrosisresearch.com. 3600 | NS | myelofibrosisresearch.com. 3600 | NS Record: pdns06.domaincontrol.com. |
myelofibrosisresearch.com. 3600 | NS | myelofibrosisresearch.com. 3600 | NS Record: pdns05.domaincontrol.com. |
Home About the Myelofibrosis Research Study About Myelofibrosis FAQs US English Australia Belgium English België Nederlands Belgique Français Česko Danmark Deutschland España Ελλάδα България France Israel English Израиль русский إسرائيل العربية ישראל 대한민국 Italia Magyarország Nederland Österreich Polska Puerto Rico English Puerto Rico Español Schweiz South Africa Sverige United Kingdom US España Are you living with myelofibrosis? Learn about a new investigational medication for myelofibrosis. You may be eligible to participate in the myelofibrosis research study if you: Are over 18 years old Have a diagnosis of myelofibrosis Are interested in participating in a clinical research study Additional study criteria will be evaluated to determine if you are eligible. Have you considered a myelofibrosis research study as part of your treatment plan for your diagnosis of myelofibrosis? The primary objective of the study is to evaluate the effect of navitoclax in combination with ruxolitinib in |
HTTP/1.1 301 Moved Permanently Date: Wed, 27 Oct 2021 11:02:09 GMT Server: Apache Location: https://myelofibrosisresearch.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 301 location: https://www.myelofibrosisresearch.com/ content-type: text/html; charset=iso-8859-1 date: Wed, 27 Oct 2021 11:02:09 GMT server: Apache HTTP/2 200 last-modified: Thu, 14 Oct 2021 17:06:25 GMT etag: "4005eb-9b4b-5ce53194b5eb2" accept-ranges: bytes content-length: 39755 vary: Accept-Encoding,User-Agent content-type: text/html date: Wed, 27 Oct 2021 11:02:09 GMT server: Apache |
Domain Name: MYELOFIBROSISRESEARCH.COM Registry Domain ID: 2545961116_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-07-15T17:47:37Z Creation Date: 2020-07-14T14:44:19Z Registry Expiry Date: 2022-07-14T14:44:19Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS31.DOMAINCONTROL.COM Name Server: NS32.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T08:28:20Z <<< |